PA
Perceptive Advisors’s Protagonist Therapeutics PTGX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $59.4M | Sell |
1,074,448
-16,823
| -2% | -$930K | 2.2% | 10 |
|
|
2025
Q1 | $52.8M | Sell |
1,091,271
-180,391
| -14% | -$8.72M | 1.86% | 12 |
|
|
2024
Q4 | $49.1M | Sell |
1,271,662
-102,901
| -7% | -$3.97M | 1.35% | 23 |
|
|
2024
Q3 | $61.9M | Buy |
1,374,563
+105,828
| +8% | +$4.76M | 1.31% | 27 |
|
|
2024
Q2 | $44M | Buy |
1,268,735
+274,412
| +28% | +$9.51M | 1.06% | 26 |
|
|
2024
Q1 | $28.8M | Buy |
994,323
+611,063
| +159% | +$17.7M | 0.5% | 56 |
|
|
2023
Q4 | $8.79M | Sell |
383,260
-671,013
| -64% | -$15.4M | 0.2% | 66 |
|
|
2023
Q3 | $17.6M | Sell |
1,054,273
-415,488
| -28% | -$6.93M | 0.59% | 47 |
|
|
2023
Q2 | $40.6M | Buy |
1,469,761
+504,609
| +52% | +$13.9M | 1.18% | 27 |
|
|
2023
Q1 | $22.2M | Buy |
+965,152
| New | +$22.2M | 0.66% | 42 |
|
|
2021
Q1 | – | Sell |
-203,591
| Closed | -$4.1M | – | 155 |
|
|
2020
Q4 | $4.1M | Buy |
+203,591
| New | +$4.1M | 0.04% | 122 |
|